MENU
+Compare
VNDA
Stock ticker: NASDAQ
AS OF
Aug 21 closing price
Price
$4.51
Change
-$0.09 (-1.96%)
Capitalization
266.49M

VNDA Vanda Pharmaceuticals Forecast, Technical & Fundamental Analysis

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients... Show more

Industry: #Biotechnology
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VNDA with price predictions
Aug 21, 2025

VNDA in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 31, 2025

VNDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where VNDA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VNDA's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 14, 2025. You may want to consider a long position or call options on VNDA as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VNDA just turned positive on August 15, 2025. Looking at past instances where VNDA's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VNDA advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where VNDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

VNDA moved below its 50-day moving average on July 31, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VNDA crossed bearishly below the 50-day moving average on August 04, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VNDA entered a downward trend on August 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VNDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.548) is normal, around the industry mean (19.773). P/E Ratio (126.000) is within average values for comparable stocks, (54.197). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.633). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.298) is also within normal values, averaging (300.579).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VNDA is expected to report earnings to fall 7.98% to -42 cents per share on October 29

Vanda Pharmaceuticals VNDA Stock Earnings Reports
Q3'25
Est.
$-0.42
Q2'25
Missed
by $0.17
Q1'25
Missed
by $0.48
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.07
The last earnings report on July 31 showed earnings per share of -46 cents, missing the estimate of -28 cents. With 393.50K shares outstanding, the current market capitalization sits at 266.49M.
A.I. Advisor
published General Information

General Information

a manufacturer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2200 Pennsylvania Avenue NW
Phone
+1 202 734-3400
Employees
203
Web
https://www.vandapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCGLY13.500.03
+0.22%
Societe Generale
CZBS46.00N/A
N/A
Citizens Bancshares Corp.
PGUCY4.50N/A
N/A
Prosegur Cash
SLLFF0.14N/A
N/A
Gusbourne PLC
TKAMY10.12-0.25
-2.44%
ThyssenKrupp AG

VNDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IVF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-1.96%
IVF - VNDA
40%
Loosely correlated
-6.25%
OCUL - VNDA
40%
Loosely correlated
+1.42%
IDYA - VNDA
38%
Loosely correlated
+1.27%
CLDX - VNDA
37%
Loosely correlated
+5.41%
EYPT - VNDA
37%
Loosely correlated
+0.78%
More